NEW YORK (awp international) – Thanks to the news of a possibly further effective vaccine against the lung disease Covid-19, the Dow Jones Industrial could break the round mark of 30,000 points on Monday for the first time in its 124-year history. The broker IG valued the US leading index about an hour before the start, 1.69 percent higher to 29 977 points. Wall Street had already shown its strong side last week.
With the pharmaceutical company Moderna, another manufacturer presented promising data for its corona vaccine. The vaccine has an effectiveness of 94.5 percent, it said in a message from Moderna. In addition, it became known that the European Medicines Agency Ema is starting a so-called rolling review process for the Moderna vaccine, which aims to achieve comparatively fast approval. Moderna shares soared in pre-market US trading by a good twelve percent.
The apparently effective vaccine from Moderna can be stored for a comparatively long time at normal refrigerator temperature. The vaccine from the manufacturer Pfizer and its German partner Biontech, on the other hand, has to be transported frozen at around minus 70 degrees to the location of the vaccination. The two companies had already presented positive data last week and thus spurred stock exchanges around the world. Pfizer’s papers went down 1.9 percent before the IPO and Biontech’s fell 7.5 percent.
Otherwise, takeovers are the focus at the beginning of the week. The major Spanish bank BBVA wants to sell its US business to the PNC Financial Services Group. Their shares gained around three percent before the market.
The DIY chain Home Depot wants to swallow the wholesaler HD Supply. Its shares soared by around 24 percent before the market, while those of Home Depot rose by 0.6 percent./la/fba
– .
